Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
P1.12 - Small Cell Lung Cancer/NET
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Small Cell Lung Cancer/NET
-
+
P1.12-01 - CD81-HOTTIP Regulating Loop Enhances Myc-Mediated Chemoresistance in Small Cell Lung Cancer via ERK Signaling Pathway
09:45 - 09:45 | Presenter: Linlang Guo | Author(s): Weimei Huang
- Abstract
Loading... -
+
P1.12-02 - Nationwide Assessment of the Role of Adjuvant Systemic Therapy in High-Risk Lung Carcinoids
09:45 - 09:45 | Presenter: Brendon M Stiles | Author(s): Mohamed K Kamel, Adam N Sholi, Ajita Naik, Sebron Harrison, Benjamin Lee, Nasser K Altorki, Jeffrey L Port
- Abstract
Loading... -
+
P1.12-03 - Antitumor Activity of Single Agent Lurbinectedin in Patients with Relapsed SCLC Occurring ≥30 Days After Last Platinum Dose
09:45 - 09:45 | Presenter: Jose Manuel Trigo Perez | Author(s): Vivek Subbiah, Benjamin Besse, Victor Moreno, Rafael López, M.Angeles Sala, Santiago Ponce, Cristian Fernendez, Antonio Nieto, Carmen Kahatt, Ali Zeaiter, Khalil Zaman, Valentina Boni, Jennifer Arrondeau, Marta Martinez, Jean Pierre Delord, Ahmad Awada, Rebeca Kristeleit, Fede Longo, John Sarantopoulos, Maria Jesús Rubio, Antonio Anton, Luciano Wannesson, Javier Valdivia, Geoffrey Shappiro, Víctor Villalobos, Armando Santoro, Manolo D'Arcangelo, Luis Aparicio, Luis Paz-Ares
- Abstract
Loading... -
+
P1.12-04 - A Phase I Study of the 177Lu-DOTA0-Tyr3-Octreotate in Combination with Nivolumab in Patients with Extensive-Stage Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Chul Kim | Author(s): Deepa S Subramaniam, Stephen V. Liu, Tisdrey Torres, Giuseppe Esposito, Guiseppe Giaccone
- Abstract
Loading... -
+
P1.12-05 - Microenvironment Characterization of Small Cell Lung Cancer Xenografts Implanted in Hematopoietic Humanized Mice
09:45 - 09:45 | Presenter: Hui Yu | Author(s): Julie Lang, Jeffrey A Kern, Shivaun Lueke Pickard, Charles M Rudin, Christopher Rivard, Fred R. Hirsch
- Abstract
Loading... -
+
P1.12-06 - Ozone-Primed Neutrophils Promote Early Steps of Tumor Cell Metastasis to Lungs by Enhancing Their NETs Production
09:45 - 09:45 | Presenter: Alison Gillard | Author(s): Natache Rocks, Céline Vanwinge, Coraline Radermecker, Silvia Blacher, Christine Gilles, Raphaël Marée, Brigitte Evrard, Christelle Pequeux, Thomas Marichal, Agnès Noël, Didier Cataldo
- Abstract
Loading... -
+
P1.12-07 - Near Infrared Photoimmunotherapy Targeting DLL3 Against Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Yoshitaka Isobe | Author(s): Kazuhide Sato, Kazuomi Takahashi, Shunichi Taki, Hirotoshi Yasui, Yuko Nishinaga, Toshinori Matsui, Yoshinori Hasegawa
- Abstract
Loading... -
+
P1.12-08 - The Impact of Patient Age and Socioeconomic Factors on Clinical Outcomes in Small Cell Lung Cancer (SCLC): A National Study
09:45 - 09:45 | Presenter: Ruqin Chen | Author(s): Abdel-Ghani Azzouqa, Rami Manochakian, Sikander Ailawadhi, Yanyan Lou
- Abstract
Loading... -
+
P1.12-09 - RNA Sequencing in Small Cell Lung Carcinoma Reveals Change in Neuroendocrine Pattern in Primary Tumor Versus Lymph Node Metastases
09:45 - 09:45 | Presenter: Zoltán Lohinai | Author(s): Zsolt Megyesfalvi, Kenichi Suda, Tünde Harkó, Ren Shengxiang, Judit Moldvay, Christopher Rivard, Balázs Döme, Fred R. Hirsch
- Abstract
Loading... -
+
P1.12-10 - The Genomic Profiles of Small Cell Lung Cancer in East Asian
09:45 - 09:45 | Presenter: Rongrong Chen | Author(s): Zheng-bo Song, Xiao-fei Wang, Jin Li, Lian-peng Chang, Yan-Fang Guan, Xuefeng Xia, Xin Yi
- Abstract
Loading... -
+
P1.12-11 - Exploring Sex Differences in Small Cell Lung Cancer: Is This a Hormonal Issue?
09:45 - 09:45 | Presenter: Narjust Duma | Author(s): Thanh P Ho, Urshila Durani, Shealeigh Funni, Jonathan Inselman, Harshita Paripati, Alex A Adjei, Julian R. Molina, Aaron S. Mansfield
- Abstract
Loading... -
+
P1.12-12 - Factors Affecting the Risk of Brain Metastasis in Limited-Stage Small Cell Lung Cancer After Prophylactic Cranial Irradiation
09:45 - 09:45 | Presenter: Mengyuan Chen | Author(s): Ming Chen, Xiao Hu
- Abstract
Loading... -
+
P1.12-13 - The Past, Present, and Future of SCLC and NSCLC Incidence, Mortality, and Prevalence in Denmark During 2006 Through 2030
09:45 - 09:45 | Presenter: Anders Green | Author(s): Karen Ege Olsen, Gitte Fredberg Persson, Mette Bliddal, Malene Hornbak, Helene Nordahl Christensen, Erik Jakobsen
- Abstract
Loading... -
+
P1.12-14 - Phase II Trial of Apatinib Plus Chemotherapy for Second-Line and Above Treatment of Advanced SCLC: Focus on Efficacy and Safety
09:45 - 09:45 | Presenter: Kewei Ma | Author(s): Yinghui Xu, Xu Wang, Yangyang Cai, Chao Sun, Ye Guo, Shi Qiu
- Abstract
Loading... -
+
P1.12-15 - PET Imaging of [18F]PARP Inhibitor as a Pharmacodynamic Biomarker of Talazoparib in Small Cell Lung Cancer PDXs
09:45 - 09:45 | Presenter: Benjamin Lok | Author(s): James Laird, Brandon Carney, Susanne Kossatz, Elisa De Stanchina, Thomas Reiner, John T Poirier, Charles M Rudin
- Abstract
Loading... -
+
P1.12-16 - LMW Heparin Adherence and Effects on Survival Within a Randomized Phase III Lung Cancer Trial (RASTEN)
09:45 - 09:45 | Presenter: Emelie Gezelius | Author(s): Par-Ola Bendahl, Kelin Gonçalves De Oliveira, Lars Ek, Bengt Bergman, Jan Sundberg, Karin Strandberg, Roland Kraemer, Mattias Belting
- Abstract
Loading... -
+
P1.12-17 - Association Between the Pharmacokinetics and Clinical Outcome of Amrubicin Treatment
09:45 - 09:45 | Presenter: Satoshi Fukuda | Author(s): Tetsuya Oguri, Osamu Takakuwa, Yusuke Kagawa, Akira Takeuchi, Kazuki Sone, Kensuke Fukumitsu, Yoshihiro Kanemitsu, Takehiro Uemura, Hirotsugu Ohkubo, Masaya Takemura, Ken Maeno, Yutaka Ito, Akio Niimi
- Abstract
Loading... -
+
P1.12-18 - Nonclinical Safety Assessment of AMG 757, a DLL3 Bispecific T Cell Engager, in the Cynomolgus Monkey
09:45 - 09:45 | Presenter: Edward K Lobenhofer | Author(s): Jonathan Werner, Michael J Giffin, Michael Engwall, Rhian Davies, Oliver Homann, Marc A Lafleur, Graeme J Moffat
- Abstract
Loading... -
+
P1.12-19 - Identification and Potential Application of Human Blood Exosomal RNA in Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Jialei Wang | Author(s): Chang Liu, Shenglin Huang, Jianhua Chang, Hui Yu, Zhengfei Zhu, Min Fan
- Abstract
Loading... -
+
P1.12-20 - Surgical Resection Versus Stereotactic Body Radiation Therapy for T1-2 N0 Typical Bronchopulmonary Carcinoid Tumors
09:45 - 09:45 | Presenter: Rodney Ervin Wegner | Author(s): Vivek Verma, Stephen Abel, Shaakir Hasan, Benny Weksler, Athanasios Colonias
- Abstract
Loading... -
+
P1.12-21 - Impact of Treatment Modality on Long-Term Survival of Small-Cell Lung Cancer with IA Stage: A Cohort Study of the US SEER Database
09:45 - 09:45 | Presenter: Kunshou Zhu
- Abstract
Loading... -
+
P1.12-22 - A Phase 1b/2 Study of Niraparib Plus Temozolomide Versus Standard Care as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer Patients
09:45 - 09:45 | Presenter: Amy Lauren Cummings | Author(s): Edward Garon, Zev A Wainberg, Jonathan Goldman
- Abstract
Loading... -
+
P1.12-23 - DLL3 Is a Predictive Marker of Sensitivity to Adjuvant Chemotherapy for High-Grade Neuroendocrine Tumors
09:45 - 09:45 | Presenter: Hiroyuki Ogawa | Author(s): Yasuhiro Sakai, Wataru Nishio, Yusuke Fujibayashi, Megumi Nishikubo, Yuki Nishioka, Shinya Tane, Yoshitaka Kitamura, Tamotsu Sudo, Yoshiko Sakuma, Masahiro Yoshimura
- Abstract
Loading... -
+
P1.12-24 - Comparison of Four Prognostic Scores for Patients with Brain Metastases from Small-Cell Lung Cancer
09:45 - 09:45 | Presenter: Lei Zhao | Author(s): Jindong Guo, Jiaming Wang, Xuwei Cai, Xiaolong Fu
- Abstract
Loading...
-
+
P1.13 - Staging
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Staging
-
+
P1.13-01 - The Importance of Staging of Lung Cancers, 30 mm or Less, Separately for Subsolid and Solid Nodules
09:45 - 09:45 | Presenter: Rowena Yip | Author(s): Yong Wang, Yeqing Zhu, Esther Fevrier, Teng Ma, Maaike Van Gerwen, David Yankelevitz, Raja Flores, Claudia I Henschke
- Abstract
Loading... -
+
P1.13-02 - Should Aortic Lymph Nodes be Considered Hilar Lymph Nodes in Patients with Completely Resected NSCLC? A Multicenter Study
09:45 - 09:45 | Presenter: Necati Citak | Author(s): Laura Guglielmetti, Yunus Aksoy, Ozgür Isgörücü, Muzaffer Metin, Adnan Sayar, Isabelle Opitz, Walter Weder, Ilhan Inci
- Abstract
Loading... -
+
P1.13-03 - Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype
09:45 - 09:45 | Presenter: Yaxing Shen | Author(s): Ting Ye, Lin Deng, Shengping Wang, Jiaqing Xiang, Yawei Zhang, Hong Hu, Yihua Sun, Yuan Li, Lei Shen, Li Xie, Wenchao Gu, Yue Zhao, Fangqiu Fu, Weijun Peng, Haiquan Chen
- Abstract
Loading... -
+
P1.13-04 - Impact of the Presence and Proportion of GGO on Survival and Pathological Characteristics in Clinical Stage I Lung Adenocarcinoma
09:45 - 09:45 | Presenter: Shinya Katsumata | Author(s): Keiju Aokage, Genichiro Ishii, Shoko Nakasone, Tomohiro Miyoshi, Kenta Tane, Masahiro Tsuboi
- Abstract
Loading... -
+
P1.13-05 - Evaluation of PET/CT Scans to Predict Pathologic Lung Cancer Staging
09:45 - 09:45 | Presenter: Mukunthan Murthi | Author(s): Rajesh Samannan, Gregory Holt
- Abstract
Loading... -
+
P1.13-06 - Impact of Lymph Node Involvement and Tumor Location on Survival Following Resection for pN1/pN2 Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Andrea Bille | Author(s): Thomas Tsitsias, Igor Saftic, Leanne Harling, Lukacs Veres, Juliet King, Karen Harrison-Phipps, Tom Routledge, John Pilling
- Abstract
Loading... -
+
P1.13-07 - Comparison of the 7th and 8th Edition of TNM Staging for NSCLC in Patients Undergoing Pulmonary Resection After Neoadjuvant/Induction Treatment
09:45 - 09:45 | Presenter: Hüseyin Melek | Author(s): Tolga Evrim Sevinç, Gamze Çetinkaya, Ahmet Sami Bayram, Adem Deligönül, Erdem Çubukçu, Türkkan Evrensel, Süreyya Sarıhan, Cengiz Gebitekin
- Abstract
Loading... -
+
P1.13-08 - The Maximum Standardized Uptake Values on Positron Emission Tomography Predict Pathological Characteristics of Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Terumoto Koike | Author(s): Yuki Shimizu, Tatsuya Goto, Seijiro Sato, Shin-ichi Toyabe, Masanori Tsuchida
- Abstract
Loading... -
+
P1.13-09 - Utility of Artificial Intelligence in Estimation of the Histologic Type of Lung Cancer
09:45 - 09:45 | Presenter: Yohei Kawaguchi | Author(s): Junji Ichinose, Yasuto Kondo, Yosuke Matsuura, Masayuki Nakao, Sakae Okumura, Mingyon Mun
- Abstract
Loading... -
+
P1.13-10 - Incidence of Hidden Extrathoracic Metastases and Unexpected Second Malignancies Detected by PET in Patients with Lung Cancer
09:45 - 09:45 | Presenter: Bruno García Cabo | Author(s): Cristina Caupena Auledas, Mireia Martinez Palau, Teodora Pribic, Roser Costa Solá, Annie Navarro Rolon, Agnes Hernandez Biette, Jose Sanz Santos, José Manuel González González, Montserrat Ysamat Marfá
- Abstract
Loading... -
+
P1.13-11 - An Audit on IASLC Compliance of Lymph Nodes Dissection and Impact on Survival After Surgery for Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Eric Lim | Author(s): Paulo De Sousa, Fatima Mansour, Monica Tavares Barbosa, Sarah Booth, Henriette Klein, Aleksander Mani, Maria Nizami, Charlotte Von Crease, George Ladas, Jonathan Finch, Nizar Asadi, Emma Beddow, Nial McGonigle, Vladimir Anikin, Sofina Begum, Simon Jordan, Angeles Montero-Fernandez, Jan Lukas Robertus, Alexandra Rice, Andrew G Nicholson
- Abstract
Loading... -
+
P1.13-12 - The Invasion of Mediastinal Fat Tissue Should be Considered for T4 Description in the Next TNM Classification of NSCLC
09:45 - 09:45 | Presenter: Necati Citak | Author(s): Yunus Aksoy, Ozgür Isgörücü, Cigdem Obuz, Baris Acikmese, Songül Büyükkale, Neslihan Akalin Fener, Muzaffer Metin, Adnan Sayar
- Abstract
Loading... -
+
P1.13-13 - High-Risk Clinical Stage I Non-Small Cell Lung Cancer Based on High-Resolution Computed Tomography Findings
09:45 - 09:45 | Presenter: Yasuhiro Tsutani | Author(s): Atsushi Kagimoto, Yoshinori Handa, Takahiro Mimae, Yoshihiro Miyata, Morihito Okada
- Abstract
Loading... -
+
P1.13-14 - Prognosis and Clinicopathologic Characteristics of Skip N2 Metastasis in Completely Resected Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Takaaki Tsuboi | Author(s): Daisuke Eriguchi, Daiji Nemoto, Joji Samejima, Takuya Nagashima, Hiroyuki Ito, Haruhiko Nakayama
- Abstract
Loading...
-
+
P1.14 - Targeted Therapy
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P1.14-01 - Are Pretreatment Inflammation-Based Prognostic Scores Useful in Predicting the Outcomes of Patients with ALK-Positive NSCLC?
09:45 - 09:45 | Presenter: Omer Fatih Olmez | Author(s): Ahmet Bilici, Pinar Gursoy, Erdem Çubukçu, Ozcan Yildiz, Abdullah Sakin, Taner Korkmaz, Ibrahim Cil, Burcu Cakar, Serkan Menekse, Tarik Demir, Ozgur Acikgoz, Jamshid Hamdard
- Abstract
Loading... -
+
P1.14-02 - Survey of EGFR Molecular Testing of NSCLC in the Asia-Pacific Region
09:45 - 09:45 | Presenter: Chong Kin Liam | Author(s): Emily Stone, Sita Andarini
- Abstract
Loading... -
+
P1.14-03 - Molecular Determinants for Lorlatinib Activity in ROS1 Positive NSCLC: Results of the Prospective PFROST Trial
09:45 - 09:45 | Presenter: Lorenza Landi | Author(s): marcello Tiseo, Lukas C Heukamp, Roopika Menon, Gianluca Spitaleri, Diego Luigi Cortinovis, Angelo Delmonte, Domenico Galetta, Manolo D'Arcangelo, Federica D'Incà, Miriam Bertrand, Balázs Jóri, Angela Zacher, Cesare Gridelli, Silvia Novello, Rita Chiari, Claudio Verusio, Lucio Crino, Federico Cappuzzo
- Abstract
Loading... -
+
P1.14-04 - Final Results of the Prospective Genomics of Young Lung Cancer (GYLC), an Addario Lung Cancer Medical Institute Study
09:45 - 09:45 | Presenter: Barbara Gitlitz | Author(s): S. Lani Park, Marisa Bittoni, Bonnie Addario, Alicia Sable-Hunt, Amy Moore, Dean C Pavlick, Silvia Novello, Tiziana Vavalà, Ruthia Chen, Geoffrey R Oxnard
- Abstract
Loading... -
+
P1.14-05 - TP53 Exon 8 Mutation and Prognosis in EGFR-Mutated NSCLC Patients Treated with First-And-Second-Generation TKIs
09:45 - 09:45 | Presenter: Paola Ulivi | Author(s): Matteo Canale, Elisabetta Petracci, Lucio Crino, Nicoletta De Luigi, Vienna Ludovini, Alessandra Dubini, Sara Baglivo, Elisa Minenza, Elisa Chiadini, Lorenza Landi, Maximilian Papi, Angelo Delmonte, Giuseppe Bronte
- Abstract
Loading... -
+
P1.14-06 - Tissue-Based Molecular and Histologic Landscape of Acquired Resistance to Osimertinib in Patients with EGFR-Mutant Lung Cancers
09:45 - 09:45 | Presenter: Adam J Schoenfeld | Author(s): Joseph Chan, Hira Rizvi, Romel Somwar, Daisuke Kubota, Yahya Daneshbod, Jason Chang, Michael Offin, Maria E. Arcila, Dana Pe'Er, Mark G Kris, Natasha Rekhtman, Gregory J Riely, Marc Ladanyi, Helena A Yu
- Abstract
Loading... -
+
P1.14-07 - Genomic Profiling of Liquid Biopsies During 2nd/3rd Generation ALK Inhibitor Therapy to Identify Novel Mechanisms of Resistance
09:45 - 09:45 | Presenter: Erin L Stewart | Author(s): Ao Wang, Ju Huang, Hua Bao, Xue Wu, Devalben Patel, Zhuo Chen, Jennifer H Law, Penelope A Bradbury, Frances Shepherd, Adrian G Sacher, Ming Sound Tsao, Scott V Bratman, Natasha B Leighl, Trevor Pugh, Geoffrey Liu
- Abstract
Loading... -
+
P1.14-08 - Activity of Poziotinib and Other 2nd-Gen Quinazoline EGFR TKIs in Atypical Exon18 and Acquired Osimertinib Resistance Mutants
09:45 - 09:45 | Presenter: Jacqulyne Ponville Robichaux | Author(s): Xiuning Le, Yasir Elamin, Monique Nilsson, Limei Hu, Junqin He, Fahao Zhang, Alissa Poteete, Huiying Sun, Waree Rinsurongkawong, Jason B Cross, John Victor Heymach
- Abstract
Loading... -
+
P1.14-09 - Unveiling Hidden MET-Mediated Primary Alectinib Resistance in ALK-Positive Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Anh Tuan Le | Author(s): Logan Tyler, Kurtis D. Davies, Kimi Kondo, Jose Pacheco, Dan Merrick, Dara Aisner, D. Ross Camidge, Robert C. Doebele
- Abstract
Loading... -
+
P1.14-10 - The Landscape of RET Genomic Alterations in Chinese Non-Small Cell Lung Cancer Patients
09:45 - 09:45 | Presenter: Yueting Qu | Author(s): Xiangyan Liu, Yucheng Wei, Xinglong Fan, Meili Ma, Junfeng Liu, Shiwang Wen, Mingjiang Li, Da Jiang, Yang Yu, Liang Song, Qiang Cui, Hui Chen, Angen Liu, Kai Wang
- Abstract
Loading... -
+
P1.14-11 - A Prospective Multicenter Study of Target-Capture Deep Sequencing in Paired Tissue and ctDNA to Guide EGFR-Mutated Lung Cancer Treatment
09:45 - 09:45 | Presenter: Shun Lu | Author(s): Xinghao Ai, Jiexia Zhang, Wen Lin, Jiuwei Cui, Congying Xie, Anwen Liu, Xiaohua Hu, qiong Zhao, chuangzhou Rao, yuansheng Zang, xiaohua Hu, Junping Zhang, Caixia Liu, Lian-peng Chang, Ningning He, Rongrong Chen, Xuefeng Xia, Xin Yi
- Abstract
Loading... -
+
P1.14-12 - A Novel Activating MAP2K1 In-Frame Deletion Mediates Acquired Resistance to ROS1 TKIs in a Patient with ROS1 Fusion-Positive NSCLC
09:45 - 09:45 | Presenter: Hiroki Sato | Author(s): Adam J Schoenfeld, Evan Siau, Ken Suzawa, Christine Yue, Michael Offin, Alexander Drilon, Monika A Davare, Gregory J Riely, Marc Ladanyi, Romel Somwar
- Abstract
Loading... -
+
P1.14-13 - EGFR Amplification Mediates Resistance to Third-Generation EGFR TKIs and in Vitro Validation of Combination Strategies to Overcome Resistance
09:45 - 09:45 | Presenter: Yi-Chen Zhang | Author(s): Qing Zhou, Zhihong Chen, Xu-Chao Zhang, Jian Su, Hao Sun, Si-yang Liu, Yi-Long Wu
- Abstract
Loading... -
+
P1.14-14 - Monitoring of EGFR Mutations During Osimertinib Treatment in Advance EGFR-Mutant T790M Positive NSCLC
09:45 - 09:45 | Presenter: Katja Mohorcic | Author(s): Andrej Janzic, Urska Janzic, Mitja Rot, Izidor Kern
- Abstract
Loading... -
+
P1.14-15 - Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey
09:45 - 09:45 | Presenter: Umut Demirci | Author(s): Saadettin Kilickap, Fatma Basal Bugdayci, Deniz Tural, Taner Korkmaz, Semra Paydas, Cengiz Yilmaz, Hande Turna, Ahmet Sezer, Havva Yesil Cinkir, Kerem Okutur, Mustafa Erman, Yesim Eralp, Devrim Cabuk, Abdurrahman Isikdogan, Ahmet Demirkazik, Aziz Karaoglu, Dogan Yazilitas, Filiz Cay Senler, Perran Fulden Yumuk, Hasan Senol Coskun, Ibrahim Yildiz, Ilhan Oztop, Ismail Beypinar, Kubra Aydin, Muhammed Ali Kaplan, Nezih Meydan, Omer Fatih Olmez, Ozgur Ozyilkan, Selcuk Seber, Cagatay Arslan, Mehmet Ali Nahit Sendur, Irfan Cicin
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.14-17 - Genomic Evolution During TKI Treatment in Non-Small Cell Lung Cancer Patients With or Without Acquired T790M Mutation
09:45 - 09:45 | Presenter: Yanjun Xu | Author(s): Ying Jin, Hua Bao, Xiuning Le, Xiaojun Fan, Ming Tang, Yun Fan, Yiping Zhang, Xun Shi, Jun Zhao, Guangyuan Lou, Lan Shao, Qiong He, Chen Lin, Jianhua Zhang, P. Andrew Futreal, Ignacio Wistuba, John Victor Heymach, Xue Wu, Yang W. Shao, Junrong Yan, Yamei Chen, Ming Chen, Jianjun Zhang, Xinmin Yu
- Abstract
Loading... -
+
P1.14-18 - ALK Inhibitor Sequencing and Outcomes Among ALK-Positive (ALK+) NSCLC Patients in the US Community Oncology Setting
09:45 - 09:45 | Presenter: Marc D Chioda | Author(s): David M Waterhouse, Janet L. Espirito, Bismark Baidoo, Jack Mardekian, Nicholas J. Robert, Elizabeth T. Masters
- Abstract
Loading... -
+
P1.14-19 - Exome Analysis of Patients Treated with Afatinib Reveals Genetic Variations Discriminating Extreme Responders
09:45 - 09:45 | Presenter: Julie Niogret | Author(s): Coureche Guillaume Kaderbhai, Sandy Chevrier, Caroline Chapusot, Caroline Truntzer, Hugo Mananet, Pascal Foucher, Bruno Coudert, Aurélie Lagrange, Laure Favier, Laurent Martin, Hamadi Almotlak, Patrick Jacoulet, Jean Lahourcade, Olivier Adotevi, Virginie Westeel, Laurent Arnould, Romain Boidot
- Abstract
Loading... -
+
P1.14-20 - Tarloxotinib as a Novel Therapeutic Strategy for Oncogenic Alterations Across the ErbB Family of Receptors
09:45 - 09:45 | Presenter: Adriana Estrada-Bernal | Author(s): Zhenfang Du, Anh Tuan Le, Adam Patterson, Jeff Smaill, Vijaya G Tirunagaru, Avanish Vellanki, Robert C. Doebele, Christine M Lovly
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P1.14-22 - SASH1, a Novel Prognostic and Predictive Factor for PARP Inhibitors in Lung Cancer
09:45 - 09:45 | Presenter: Joshua Burgess | Author(s): Emma Bolderson, Derek Richard, Kenneth John O’Byrne
- Abstract
Loading... -
+
P1.14-23 - Resistance Mechanisms to Osimertinib Treatment in EGFR-Mutated Lung Cancer in a Real Life Cohort
09:45 - 09:45 | Presenter: Christi M.J. Steendam | Author(s): Peggy Atmodimedjo, Marthe S Paats, Cor Van Der Leest, Jan H. Von Der Thüsen, Winand N.M. Dinjens, Ron H.N. Van Schaik, Hendrikus Jan Dubbink, Joachim G.J.V. Aerts
- Abstract
Loading... -
+
P1.14-24 - Characterization of Acquired Receptor Tyrosine Kinase Fusions as Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors
09:45 - 09:45 | Presenter: Haiyuan Xu | Author(s): Yongqian Shu, Hong Jian, Jinge Shen, Jianxing Xiang, Haiyan Li, Bing Li, Tengfei Zhang, Lu Zhang, Xinru Mao
- Abstract
Loading... -
+
P1.14-25 - Targeting NRG1-Fusions in Lung Adenocarcinoma: Afatinib as a Novel Potential Treatment Strategy
09:45 - 09:45 | Presenter: Michael Duruisseaux | Author(s): Janessa J. Laskin, Khaled Tolba, Eva Brandén, Yasushi Goto, Robert C. Doebele, Parneet Kaur Cheema, Jacques Cadranel, Martin R. Jones, Alexander Drilon, Domenico Trombetta, Lucia A. Muscarella, Agnieszka Cseh, Flavio Solca, Stephen V. Liu
- Abstract
Loading... -
+
P1.14-26 - ALK Fusion Variant Detection by Targeted RNA-Seq in TKIs Treated ALK-Positive Lung Adenocarcinoma
09:45 - 09:45 | Presenter: Fabrizio Tabbò | Author(s): Elisa Gobbini, Lucia Anna Muscarella, Angelica Rigutto, Domenico Trombetta, Antonio Bonfitto, Domenico Galetta, Evaristo Maiello, Olga Martelli, marcello Tiseo, Paola Bordi, Vieri Scotti, Laura Ghilardi, Vanesa Gregorc, Concetta Sergi, Sara Pilotto, Alessandro Del Conte, Federico Cappuzzo, Diego Luigi Cortinovis, Giorgia Osman, Claudia Bareggi, Massimo Di Maio, Antonio Rossi, Giulio Rossi, Emilio Bria, Marco Volante, Giorgio Vittorio Scagliotti, Paolo Graziano, Silvia Novello, luisella Righi
- Abstract
Loading... -
+
P1.14-27 - Duration of Targeted Therapy in Advanced NSCLC (aNSCLC) with Drivers Identified by Circulating Tumor DNA (ctDNA) Analysis
09:45 - 09:45 | Presenter: Christina Baik | Author(s): Tejas Patil, Kedar Kirtane, Rafael Santana-Davila, Thereasa Rich, Carin Espenschied, Caroline Weipert, Stephanie Mach, Karen L Reckamp, Robert C. Doebele
- Abstract
Loading... -
+
P1.14-28 - Correlation Between the Qualification for the Bevacizumab Use and the Survival of NSCLC Patients with EGFR Mutations
09:45 - 09:45 | Presenter: Taiki Hakozaki | Author(s): Yusuke Okuma, Kana Hashimoto, Yukio Hosomi
- Abstract
Loading... -
+
P1.14-29 - Disrupting the Paradigm: Partnering with Oncogene-Focused Patient Groups to Propel Research
09:45 - 09:45 | Presenter: Janet Freeman-Daily | Author(s): Bonnie Addario, Colin Barton, Upal Basu Roy, Shelley B Blam, Ivy Elkins, Jill Feldman, Anita Figueras, Robert Hanlon, Marcia Karen Horn, Pasi A Jänne, Christine M Lovly, Amy Moore, Terry L Ng, Alicia Sable-Hunt, Sandra Shaw, Robert C. Doebele
- Abstract
Loading... -
+
P1.14-30 - Phase I Study of Afatinib Plus Bevacizumab in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations
09:45 - 09:45 | Presenter: Takaaki Tokito | Author(s): Ryo Ko, Chiyo K Imamura, Takehito Shukuya, Naoko Shimada, Ryo Koyama, Kazuhiko Yamada, Hidenobu Ishii, Koichi Azuma, Kazuhisa Takahashi
- Abstract
Loading... -
+
P1.14-31 - Lack of Association Between BIM Deletion Polymorphism and Clinical Efficacy of EGFR-TKIs in NSCLC Based on NGS
09:45 - 09:45 | Presenter: Si-Yang Liu | Author(s): Wen-Feng Li, Hao Sun, Yi-Chen Zhang, Jia-Ying Zhou, Jin-Ji Yang, Yi-Long Wu
- Abstract
Loading... -
+
P1.14-32 - Rash and Efficacy in Anaplastic Lymphoma Kinase Positive (ALK+) Non-Small Cell Lung Cancer Patients Treated with Ensartinib
09:45 - 09:45 | Presenter: Heather A Wakelee | Author(s): Karen L Reckamp, Ticiana A. Leal, Alberto Chiappori, Saiama Waqar, Karen Zeman, Joel W Neal, Chris Liang, Kim Harrow, Allison Holzhausen, Joey Zhou, Giovanni Selvaggi, Leora Horn
- Abstract
Loading... -
+
P1.14-33 - Canagliflozin Inhibits Lung Cancer Survival and Enhances Its Response to Radiotherapy; Effective Blockade of mTOR Pathway, HIF1a, and Mitosis
09:45 - 09:45 | Presenter: Evangelia Evelyn Tsakiridis | Author(s): Olia Demetra Biziotis, Panagiotis Zacharidis, Lindsay Broadfield, Bassem Mekhaeil, Gabe Menjolian, Thomas Farell, Bassam Abdulkarim, Paola Muti, Gregory Steinberg, Theodoros Tsakiridis
- Abstract
Loading... -
+
P1.14-34 - The Landscape of MET Alterations in Chinese Non-Small Cell Lung Cancer Patients
09:45 - 09:45 | Presenter: Yueting Qu | Author(s): Min Zheng, Peng Jun, Shoufeng Wang, Mu Li, Naiquan Mao, Yinqiang Liu, Tianli Cheng, Haitao Lan, Juan Zhao, Wenjing Wang, Jinwei Hu, Ming Yao, Kai Wang
- Abstract
Loading... -
+
P1.14-35 - Epithelial-To-Mesenchymal Transition Is a Mechanism of ALK Inhibitor Resistance in Lung Cancer Independent of ALK Mutation Status
09:45 - 09:45 | Presenter: Koji Fukuda | Author(s): Shinji Takeuchi, Sachiko Arai, Shigeki Nanjo, Ryohei Katayama, Kengo Takeuchi, Makoto Nishio, Seiji Yano
- Abstract
Loading... -
+
P1.14-36 - Phase II Trial of Afatinib in Elderly Patients Aged Over 75 Years with EGFR Mutation Positive Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Ryo Ko | Author(s): Satoshi Oizumi, Hidenori Mizugaki, Yuka Fujita, Toshiyuki Harada, Taichi Takashina, Satoshi Igawa, Kageaki Watanabe, Takamasa Hotta, Hiroyuki Minemura, Sho Saeki, Shigehiro Yagishita, Akinobu Hamada
- Abstract
Loading... -
+
P1.14-37 - Lung Cancer in Never-Smokers: A Nationwide Population Based Mapping of Targetable Alterations
09:45 - 09:45 | Presenter: Maria Planck | Author(s): Annette Salomonsson, Mats Jönsson, Christel Reuterswärd, Annelie F Behndig, Bengt Bergman, Johan Botling, Eva Brandén, Hans Brunnström, Luigi De Petris, Aziz Hussein, Mikael Johansson, Hirsh Koyi, Kristina Lamberg Lundström, Rolf Lewensohn, Nastaran Monsef, Cristian Ortiz-Villalón, Annika Patthey, Anders Vikström, Gunnar Wagenius, Johan Staaf
- Abstract
Loading... -
+
P1.14-38 - Identification of FGFR1-3 Fusions in Lung Cancers Using Comprehensive Next-Generation Sequencing
09:45 - 09:45 | Presenter: Gen Lin | Author(s): Mingming Yuan, Panwen Tian, Likun Chen, Chunmei Shi, Yifen Wu, Fenglei Yu, Lingjun Zhu, Rongrong Chen, Xuefeng Xia
- Abstract
Loading... -
+
P1.14-39 - Acquired ALK Rearrangement in EGFR-Mutant Lung Adenocarcinoma Treated with EGFR TKIs
09:45 - 09:45 | Presenter: Qian-Yu Wang | Author(s): Rui-Lian Chen, Jin Kang, Hua-Jun Chen, Bin-Chao Wang, Zhen Wang, Qing Zhou, Yi-Long Wu, Jin-Ji Yang
- Abstract
Loading... -
+
P1.14-40 - EGFR-TKIs May Sensitize Radiation Lung Damage in Stereotactic Body Radiotherapy Based on Intensity Analyzing
09:45 - 09:45 | Presenter: Xingni Tang | Author(s): Yichao Shen, Yinnan Meng, Liqiao Hou, Chao Zhou, Changhui Yu, Wei Wang, Haihua Yang, Feng-Ming Spring Kong
- Abstract
Loading... -
+
P1.14-41 - The Combination of the PARP Inhibitor Olaparib and the ATR Inhibitor VE-821 Selectively Targets ATM-Deficient Lung Cancer Cells
09:45 - 09:45 | Presenter: Nicholas Jette | Author(s): Suraj Radhamani, Greydon Arthur, Ruiqiong Ye, Siddhartha Goutam, Anthony Boylos, Lars Frederick Petersen, Pinaki Bose, Gwyn Bebb, Susan Lees-Miller
- Abstract
Loading... -
+
P1.14-42 - Apatinib Combined with EGFR - TKI in Treating Advanced Non-Small Cell Lung Cancer with EGFR - TKI Resistance (Data Updated)
09:45 - 09:45 | Presenter: Ruifen Tian | Author(s): Xia Song, Yi Guo, Xia Zhang, Wei Guo, Haibo Zhu, Fangfang Shen, Junjun Xu, Xing Zhang, Rong Wang, Xiaohui Ren, Jing Li
- Abstract
Loading... -
+
P1.14-43 - A Novel Patient Derived Synchronous Cell Pair with Different Mutations in an ALK-Rearranged Lung Adenocarcinoma Underlines Tumor Heterogeneity
09:45 - 09:45 | Presenter: Paul Stockhammer | Author(s): Cassandra Su Lyn Ho, Agnes Bankfalvi, Till Plönes, Luca Hegedus, Martin Schuler, Clemens Aigner, Alexander Schramm, Balazs Hegedus
- Abstract
Loading... -
+
P1.14-44 - Positive PD-L1 Expression Is Associated with Unfavorable Clinical Outcome in EGFR-Mutated Lung Adenocarcinomas Treated with EGFR-TKIs
09:45 - 09:45 | Presenter: Boksoon Chang | Author(s): Seung Hyeun Lee, Myung Jae Park
- Abstract
Loading... -
+
P1.14-45 - Surgical Outcome of Non-Small Cell Lung Cancer with Clinical Single Zone N2 in Aortopulmonary Zone (LN#5 and LN#6)
09:45 - 09:45 | Presenter: Kanghoon Lee | Author(s): Hyeong Ryul Kim, Jin-Sook Ryu, Yong-Il Kim, Seung-Il Park, Dong Kwan Kim, Yong-Hee Kim, Sehoon Choi, Geun Dong Lee, Yong Ho Jeong, Jae Kwang Yun, Yooyoung Chong
- Abstract
Loading... -
+
P1.14-46 - Genomic Profiling of Large Cell Neuroendocrine Carcinomas of Lung: A Path Towards Individualized Treatment Options
09:45 - 09:45 | Presenter: Nhu Thi Ngo | Author(s): Julia A. Elvin, Jo-Anne Vergilio, J. Keith Killian, Douglas Lin, Jeff Ross
- Abstract
Loading... -
+
P1.14-47 - ctDNA NGS for Guiding Crizotinib Treatment in ALK-Rearranged Advanced NSCLC Patients (Pts)
09:45 - 09:45 | Presenter: Yong He | Author(s): Jun Zhao, Caixia Liu, Rongrong Chen, Xuefeng Xia
- Abstract
Loading... -
+
P1.14-48 - Whole Exome Sequencing (WES) in Non-Small Cell Lung Carcinoma (NSCLC): Identification of Novel Biomarkers
09:45 - 09:45 | Presenter: Varsha Singh | Author(s): Amit Katiyar, Prabhat Singh Malik, Anant Mohan, Harpreet Singh, Deepali Jain
- Abstract
Loading... -
+
P1.14-49 - The Role of ctDNA Detection (Liquid Biopsy) in Patients with NSСLC
09:45 - 09:45 | Presenter: Albina Zhabina | Author(s): Fedor Moiseenko, Mariya Stepanova, Vladimir Moissenko, Aleksandr Mjslik, Nikita Volkov, Darya Krylova, Nikita Rysev
- Abstract
Loading... -
+
P1.14-50 - A Phase 2 Trial of Cabozantinib in ROS1-Rearranged Lung Adenocarcinoma
09:45 - 09:45 | Presenter: Robin Guo | Author(s): Isabel Preeshagul, Adam J Schoenfeld, Caroline G. McCarthy, Alex Makhnin, Andrew J. Plodkowski, Michelle S. Ginsberg, Monika A Davare, Lukas Delasos, Romel Somwar, Maria E. Arcila, Gregory J Riely, Natasha Rekhtman, Marc Ladanyi, Mark G Kris, Alexander Drilon
- Abstract
Loading... -
+
P1.14-51 - LOC440416 lncRNA-Mediated Cell Cycle Arrest Regulated Crizotinib-Induced Hepatotoxicity
09:45 - 09:45 | Presenter: Xueqin Chen
- Abstract
Loading... -
+
P1.14-52 - Clinical Response to Osimertinib in a Patient with Metastatic NSCLC Harboring EGFR A763_Y764insFQEA Exon 20 Insertion Mutation: A Case Report
09:45 - 09:45 | Presenter: Gabriela Liliana Bravo Montenegro | Author(s): Chul Kim
- Abstract
Loading... -
+
P1.14-53 - Co-Occurring CDKN2A/2B Alteration Is Associated with Poorer Survival in ALK-Positive Lung Cancer
09:45 - 09:45 | Presenter: Joo Young Ha | Author(s): Shinkyo Yoon, Dae Ho Lee, Jene Choi, Sang-we Kim
- Abstract
Loading... -
+
P1.14-54 - Previous Therapy Strategy Impact on Efficiency of Anlotinib Hydrochloride as 3rd Line Treatment: A Subgroup Analysis of ALTER0303 Trial
09:45 - 09:45 | Presenter: Sen Yang | Author(s): Lili Wang, Qiming Wang
- Abstract
Loading... -
+
P1.14-55 - Cost-Effectiveness of Ceritinib and Alectinib vs Crizotinib in First-Line Anaplastic Lymphoma Kinase-Positive Advanced NSCLC
09:45 - 09:45 | Presenter: Bin Wu | Author(s): YanWen Xie, Hongchao Li
- Abstract
Loading... -
+
P1.14-56 - The Dynamic Range of Mutant Allele Fraction Detected in ctDNA from Patients with NSCLC: Clinical Experience Data and Clinical Implications
09:45 - 09:45 | Presenter: Veena M Singh | Author(s): Smitha Boorgula, Julie Ann Mayer, Deanna Fisher
- Abstract
Loading... -
+
P1.14-57 - Post-Ensartinib Outcomes in Refractory Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC)
09:45 - 09:45 | Presenter: Sandip Pravin Patel | Author(s): Hans Kim, Peter Vu, Kim Harrow, Chris Liang, Giovanni Selvaggi, Elizabeth Weihe, William Mitchell, Lyudmila Bazhenova
- Abstract
Loading... -
+
P1.14-58 - A Phase II Study to Evaluate Neoadjuvant Osimertinib for Surgically Resectable, EGFR-Mutant Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Collin M Blakely | Author(s): Julia Rotow, Anatoly Urisman, Caroline McCoach, Thierry M Jahan, Trever G Bivona, Kirk Jones, Anshal Gupta, Hien Do, Jonathan Wesley Riess, Dara Aisner, Robert C. Doebele, David M Jablons, Johannes Kratz
- Abstract
Loading... -
+
P1.14-59 - Clinical Implications of the Pharmacokinetics of Dacomitinib Co-Administration with H2-Receptor Antagonists in Cancer Patients
09:45 - 09:45 | Presenter: Swan Lin | Author(s): Weiwei Tan
- Abstract
Loading... -
+
P1.14-60 - Statins Overcome Resistance to Tyrosine Kinase Inhibitors in Patient-Derived, Oncogene-Driven NSCLC Models
09:45 - 09:45 | Presenter: Weijie Ma | Author(s): Eddie Tian, Qianping Li, Sixi Wei, Chihong Zhou, Ken Y Yoneda, Tianhong Li
- Abstract
Loading... -
+
P1.14-61 - EGFR Inhibitors Plus Bevacizumab Are Superior Compared to EGFR Inhibitor Monotherapy in Advanced EGFR+ NSCLC Patients with BIM Deletions
09:45 - 09:45 | Presenter: Oscar Gerardo Arrieta | Author(s): Andrés Felipe Cardona, Alejandro Ruiz-Patiño, Zyanya Lucia Zatarain Barrón, Luis Leonardo Rojas, Luis Corrales, Claudio Martin, Feliciano Barrón, Carolina Sotelo, July Rodriguez, Luisa Ricaurte, Jenny Ávila, Diana Mayorga, Pilar Archila, Jorge Otero, Helano C. Freitas, Vladmir Cláudio Cordeiro De Lima, Luis Mas, Hernán Carranza, Carlos Vargas, Rafael Rosell
- Abstract
Loading... -
+
P1.14-62 - Afatinib in EGFR TKI-Naïve Patients with EGFR Mutation-Positive NSCLC: Combined Analysis of Two Single-Arm Phase IIIb Studies
09:45 - 09:45 | Presenter: BJ Srinivasa | Author(s): Filippo De Marinis, Haiyan Tu, Konstantin Laktionov, Artem Poltoratskiy, Jun Zhao, Inna Egorova, Eng-Huat Tan, Maya Gottfried, Victor Lee, Dariusz Kowalski, Cheng-Ta Yang, Antonio Passaro, Laura Clementi, Wenbo Tang, Dennis Chin-Lun Huang, Agnieszka Cseh, Caicun Zhou, Yi-Long Wu
- Abstract
Loading...
-
+
P1.15 - Thymoma/Other Thoracic Malignancies
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Thymoma/Other Thoracic Malignancies
-
+
P1.15-01 - Prognostic Factors and Long-Term Outcomes After Pulmonary Metastasectomy from Renal Cell Carcinoma
09:45 - 09:45 | Presenter: Domenico Galetta | Author(s): Lorenzo Spaggiari
- Abstract
Loading... -
+
P1.15-02 - Role of mTOR Inhibitor Everolimus in the Treatment of Metastatic Thymic Epithelial Tumors
09:45 - 09:45 | Presenter: Jessica Hellyer | Author(s): Sukhmani Padda, Shireen Vali, Arko Das, Huzaifa Sikora, Zakir Husain, Ansu Kumar, Taher Abbasi, Heather A Wakelee
- Abstract
Loading... -
+
P1.15-03 - Cabozantinib and R428 Inhibit the Growth of Esophageal Squamous Cell Carcinoma (ESCC)
09:45 - 09:45 | Presenter: Pei-Wen Yang | Author(s): Jang-Ming Lee, Min-Shu Hsieh
- Abstract
Loading... -
+
P1.15-04 - Multimodality Treatment of Chest Wall Tumors: Induction Therapy Reduces Recurrence Rates
09:45 - 09:45 | Presenter: Milos Sarvan | Author(s): Martina Friess, Ilhan Inci, Didier Schneiter, Walter Weder, Isabelle Opitz
- Abstract
Loading... -
+
P1.15-05 - Genomic Variation Landscape of Thymoma and Thymic Carcinoma in Chinese Patients
09:45 - 09:45 | Presenter: Naixin 13701089919 Liang | Author(s): Lei Liu, Hongsheng Liu, Weiwei Wang, Yalan Bi, Zhiyong Liang, Nan Li, Rui Lin, Tao Wang, Shanqing Li
- Abstract
Loading... -
+
P1.15-06 - Resection of Thoracic Paragangliomas: A Multicenter Experience
09:45 - 09:45 | Presenter: Edward Y. Chan | Author(s): Sergio Ibarra, Ross Reul, Min Kim, Thomas Macgillivray, Vinod Ravi, Michael Reardon
- Abstract
Loading... -
+
P1.15-07 - Combined Aortic Arch Resection for Thymic Cancer Using Total Rerouting of Supra-Arch Vessels
09:45 - 09:45 | Presenter: Yasushi Shintani | Author(s): Soichiro Funaki, Naoko Ose, Takashi Kanou, Eriko Fukui, Kenji Kimura
- Abstract
Loading... -
+
P1.15-08 - Outcomes of T4 Esophageal Cancer Treated with Neoadjuvant Chemoradiation Followed by Surgery and Definitive Chemoradiation: A Meta-Analysis
09:45 - 09:45 | Presenter: Chia Ching Lee | Author(s): Yu Yang Soon, Jeremy Chee Seong Tey
- Abstract
Loading... -
+
P1.15-09 - The Impact of Minimal Invasive Esophagectomy and Neoadjuvant Chemoradiotherapy for Esophageal Malignancy: A Nationwide Database Analysis
09:45 - 09:45 | Presenter: Cheng-Hung How | Author(s): Jang-Ming Lee
- Abstract
Loading... -
+
P1.15-10 - Trabectedin Has Limited Clinical Activity in Pretreated Patients with Pleural Mesothelioma
09:45 - 09:45 | Presenter: Antonio Chella | Author(s): Giulia Pasquini, Lacopo Petrini, Roberto Castellana, Irene Pecora, Caterina Vivaldi, Maurizio Lucchesi, Alfredo Falcone
- Abstract
Loading... -
+
P1.15-11 - Intrathoracic Neurogenic Tumors: Clinical, Pathological, and Long-Term Outcomes
09:45 - 09:45 | Presenter: Domenico Galetta | Author(s): Lorenzo Spaggiari
- Abstract
Loading... -
+
P1.15-12 - A Different Aspect to Tumor Size Dilemma in Thymoma's TNM Staging Classification
09:45 - 09:45 | Presenter: UĞURUM Ayşe Yücemen | Author(s): Ayten Kayi Cangir, Tamer Direk, Bülent Mustafa Yenigün, Gökhan Kocaman, Yusuf Kahya, Serkan Enön, Serpil Dizbay Sak
- Abstract
Loading... -
+
P1.15-13 - Subxiphoid Uniportal Thoracoscopic Thymectomy Without Carbon Dioxide Insufflation in the Patients with Thymoma
09:45 - 09:45 | Presenter: Do Kyun Kang | Author(s): Min Kyun Kang
- Abstract
Loading...
-
+
P1.16 - Treatment in the Real World - Support, Survivorship, Systems Research
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Treatment in the Real World - Support, Survivorship, Systems Research
-
+
P1.16-01 - Complications Associated with Lung Biopsies in Patients with Lung Cancer: A Population Based Analysis
09:45 - 09:45 | Presenter: David E. Gerber | Author(s): Mitchell Von Itzstein, Arjun Gupta, Kristen Mara, Sahil Khanna
- Abstract
Loading... -
+
P1.16-02 - The Real-World Risk of Brain Metastases in Stage 3 Lung Cancer Patients in the Era of PET and MRI Staging
09:45 - 09:45 | Presenter: Seema Nagpal | Author(s): Ryan Brendan Ko, Kate Elizabeth Therkelsen, Rie Von Eyben, Joel W Neal, Billy W Loo
- Abstract
Loading... -
+
P1.16-03 - Incidence and Risk Factors of Metachronous Non-Pulmonary Malignancies in Resected Lung Adenocarcinoma
09:45 - 09:45 | Presenter: Peter J Kneuertz | Author(s): Desmond M D'Souza, Morgan Richardson, Mahmoud Abdel-Rasoul, Susan D Moffatt-Bruce, ROBERT E Merritt
- Abstract
Loading... -
+
P1.16-04 - Real World Experience of Using Comprehensive Genomic Profiling of Plasma Circulating Tumor DNA
09:45 - 09:45 | Presenter: Yan Yan | Author(s): Weijie Ma, Michael Molmen, Trey Regalo, Dean C Pavlick, Brady Forcier, Bethany Sawchyn, Shuai Chen, Jeffrey Gregg, Tianhong Li
- Abstract
Loading... -
+
P1.16-05 - Incidence and Outcome of Multiple Primary Cancers (MPC) in a Series of Lung Cancer (LC) Patients
09:45 - 09:45 | Presenter: Susana Cedres | Author(s): Alberto Hernando-Calvo, Patricia Iranzo, Ana Callejo, Nuria Pardo Aranda, Alejandro Navarro, Alex Martinez-Marti, Juan D Assaf, Josep M Miquel, Gisela Rodriguez, Victor Monton, Anna Pedrola, Cristina Viaplana, Caterina Carbonell, Miriam Sanso, Rodrigo Dienstmann, Ramon Amat, Ana Vivancos, Enriqueta Felip
- Abstract
Loading... -
+
P1.16-06 - Early Changes in Pulmonary Function Are Associated with Development of Pneumonitis in NSCLC Patients Receiving Immune Checkpoint Blockade
09:45 - 09:45 | Presenter: Joshua Reuss | Author(s): Karthik Suresh, Kevin Psoter, Patrick M. Forde, Jarushka Naidoo
- Abstract
Loading... -
+
P1.16-07 - Real World Evidence of the Impact of Immunotherapy in Patients with Advanced Lung Cancer
09:45 - 09:45 | Presenter: Natasha B Leighl | Author(s): Christopher Pettengell, Jennifer H Law, Lisa Le, Mike R Sung, Sally CM Lau, Adrian G Sacher, David C Merritt, Patricia Demarco
- Abstract
Loading... -
+
P1.16-08 - Integration of Durvalumab into the Treatment of Stage III Non-Small Cell Lung Cancer: Real-World Considerations
09:45 - 09:45 | Presenter: Sophia Valesca Gorgens | Author(s): Eduard Schreibmann, Madhusmita Behera, Conor E Steuer, Rathi N Pillai, Taofeek Owonikoko, Joseph W Shelton, Suresh S Ramalingam, Walter J Curran, Kristin A Higgins
- Abstract
Loading... -
+
P1.16-09 - Post-Progression Outcomes After Pembrolizumab in Patients with NSCLC and High PD-L1 Expression: Real-World Data from a European Cohort
09:45 - 09:45 | Presenter: Giannis Mountzios | Author(s): Giulio Metro, Diego Signorelli, Juliana Rey-Cobo, Marco Banini, Panagiota Economopoulou, Giuseppe Lo Russo, Panagiotis Baxevanos, Fausto Roila, Alessandro De Toma, Giuseppe Banna, Athina Christopoulou, Beatriz Jimenez, Ana Collazo-Lorduy, Helena Linardou, Antonio Calles Blanco, Domenico Galetta, Alfredo Addeo, Andrea Camerini, Paris Kosmidis, Marina Chiara Garassino
- Abstract
Loading... -
+
P1.16-10 - Real-World Efficacy of First-Line Pembrolizumab in Patients with Advanced PD-L1 High Non-Small Cell Lung Cancer in Argentina
09:45 - 09:45 | Presenter: Gonzalo Recondo Jr. | Author(s): Alejandro Daniel Kuzminin, Nicolás Minatta, Maria Virginia Bluthgen, Manglio Miguel Rizzo, Martin Naveira, Vanina Wainsztein, Lorena Lupinacci, Maria Florencia Rizzi, Maria Victoria Faura, Aldo Agustin Perfetti
- Abstract
Loading... -
+
P1.16-11 - A Dyad-Based Mindfulness Cancer Recovery Program for Survivors and Family Members to Reduce Lung Cancer Symptoms
09:45 - 09:45 | Presenter: Karen Kane McDonnell | Author(s): Otis LeShaun Owens, David G. Gallerani, Jenay M Beer, James G. Hardin, Amanda R. Bennett, Lisa Webb
- Abstract
Loading... -
+
P1.16-12 - An Analysis of Healthcare Use and the Cost Associated to End-of-Life Care of Lung Cancer Patients in a Spanish Hospital
09:45 - 09:45 | Presenter: Mariano Provencio | Author(s): Juan Luis Cruz, Ernestina Menasalvas, Consuelo Parejo, Francisco Martínez-Ruíz, Juan Cristóbal Sánchez-González, Raquel Gómez-Bravo, Arturo Ramos Martín-Vegue, Ana Royuela, Alejandro Rodríguez-González
- Abstract
Loading... -
+
P1.16-13 - Development of a Veterans Affairs Based Comprehensive Lung Cancer Survivorship Program
09:45 - 09:45 | Presenter: Scott Shofer | Author(s): Alisa Hassinger, Jordan Stafford, Robert Kundich, Anne Mathews, Scott Swartzwelder
- Abstract
Loading... -
+
P1.16-14 - Effects of an Artificial Intelligence (AI) System on Clinical Trial Enrollment in Lung Cancer
09:45 - 09:45 | Presenter: Konstantinos Leventakos | Author(s): Jane Helgeson, Aaron S. Mansfield, Erin Deering, Anna Schwecke, Alex A Adjei, Julian R. Molina, Craig Hocum, Kaushal Parikh, Thorvardur Halfdanarson, Randolph Marks, Troy Bleeker, Katharine Pomerleau, Sadie Coverdill, Melissa Rammage, Anita Preininger, Gretchen Purcell Jackson, Tufia Haddad
- Abstract
Loading... -
+
P1.16-15 - Rates of Systemic Anticancer Therapy (SACT) for Advanced Non-Small Cell Lung Cancer (aNSCLC) in the US, 2011–2018
09:45 - 09:45 | Presenter: Vamsidhar Velcheti | Author(s): Sheenu Chandwani, Xin Chen, Bilal Piperdi, Thomas Burke
- Abstract
Loading... -
+
P1.16-16 - Lung Cancer Control in Sub-Saharan Africa: Experience at Ampath Oncology in Western Kenya
09:45 - 09:45 | Presenter: Fredrick Chite Asirwa | Author(s): Lawrence Atundo, Hillary Kibet
- Abstract
Loading... -
+
P1.16-17 - Getting to Know Our Weapons Better. Analyze from Real Life Data from León, Spain
09:45 - 09:45 | Presenter: Luis Felipe Sánchez-Cousido | Author(s): Mariam Rojas Piedra, Mariana López Flores, Irene Pilar Delgado Sillero, Ana López González, Carmen Castañón, Beatriz Nieto Mangudo, Manuela Pedraza, Luis De Sande, Soledad Medina, Ángel Rodriguez, Andrés García-Palomo, Pilar Diz Tain
- Abstract
Loading... -
+
P1.16-18 - Pleural Malignant Effusion. Is it Possible to Predict Recurrence After Palliative Pleural Procedure?
09:45 - 09:45 | Presenter: Fernando Conrado Abrao | Author(s): Igor Abreu, Mariana Oliveira, Geisa Viana, Riad Younes, Elnara Marcia Negri
- Abstract
Loading... -
+
P1.16-19 - Understanding Physician Barriers in the Management of Lung Cancer in Nepal. Can Educational Intervention Make a Difference?
09:45 - 09:45 | Presenter: Ramila Shilpakar | Author(s): Bishnu Dutta Paudel, Michael Glode, Aarati Shah, Soniya Dulal, Bibek Acharya, Prakash Neupane
- Abstract
Loading... -
+
P1.16-20 - Trial in Progress: Cardiac Toxicity in Patients Undergoing Curative Intent Radiotherapy for Lung Cancer
09:45 - 09:45 | Presenter: Kathryn Elizabeth Banfill | Author(s): Fei Sun, Alan McWilliam, Azadeh Abravan, John Lilley, Bob Wheller, Matthias Schmitt, Kevin Franks, Marcel Van Herk, Corinne Faivre-Finn
- Abstract
Loading... -
+
P1.16-21 - Does Age Affect What Patients Value When Considering Lung Cancer Treatments? Evidence from a National Survey
09:45 - 09:45 | Presenter: Upal Basu Roy | Author(s): Carolyn J Presley, Sarah A Janse, Eric R Anderson, Kathleen Gallagher, Andrea S Ferris, Ellen M Janssen, John FP Bridges
- Abstract
Loading... -
+
P1.16-22 - Reduced Delays in Diagnostic Pathways for Non-Small Cell Lung Cancer After Local and National Interventions
09:45 - 09:45 | Presenter: Dan Lærum | Author(s): Lars Fjellbirkeland, Odd Terje Brustugun, Frode Gallefoss, Ragnhild Falk, Trond-Eirik Strand
- Abstract
Loading... -
+
P1.16-23 - Comparison of Electronic and Traditional Thoracic Drainage Systems for Postoperative Chest Tube Management After Pulmonary Resection
09:45 - 09:45 | Presenter: Ching Feng Wu
- Abstract
Loading... -
+
P1.16-24 - Detection of Plasma T790M Mutation After the First Generation EGFR-TKI Resistance of Non-Small Cell Lung Cancer in the Real World
09:45 - 09:45 | Presenter: Haiyan Li | Author(s): Dongqing Lv, Hailin Xu, Minhua Ye, Xiaomai Wu, Feng-Ming Spring Kong, Haihua Yang
- Abstract
Loading... -
+
P1.16-25 - Impact of Pirfenidone on the Risk Scoring System of Postoperative Acute Exacerbation of Interstitial Pneumonia in Lung Cancer
09:45 - 09:45 | Presenter: Ryohei Matsushima | Author(s): Kosuke Fujino, Hironobu Osumi, Koei Ikeda, Takeshi Mori, Makoto Suzuki
- Abstract
Loading... -
+
P1.16-26 - Epithelial Growth Factor Receptor Mutation Pattern in Non-Small Cell Lung Cancer of Xuanwei Region in Southwestern China
09:45 - 09:45 | Presenter: Jie Lin | Author(s): Li Lv, Zhichao Liu, Yang Liu, Wenhui Zhang, Lifeng Jiang, Wenhua Liang
- Abstract
Loading... -
+
P1.16-27 - Risk Factors Associated with a Second Primary Lung Cancer (SPLC) in Patients (Pts) with an Initial Primary Lung Cancer (IPLC)
09:45 - 09:45 | Presenter: Misako Nagasaka | Author(s): Dina Farhat, Kimberly Belzer, Seongho Kim, Mary Ann Milczuk, Hirva Mamdani, Ammar Sukari, Antoinette Josephine Wozniak
- Abstract
Loading... -
+
P1.16-28 - The Humanistic Burden of ALK+ NSCLC: Findings from the ALKConnect Patient Insight Network and Research Platform
09:45 - 09:45 | Presenter: Huamao Mark Lin | Author(s): Xiaoyun Pan, Alyssa Biller, Kyla J Covey, Hui Huang, Vanessa Rangel Miller, Meira Smith, HOWARD WEST
- Abstract
Loading... -
+
P1.16-29 - Profiling Immune-Related Adverse Events (irAEs) in Patients with Anti-PD-1 for Advanced Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Yukihiro Toi | Author(s): Shunichi Sugawara, Mari Aso, Kyoji Tsurumi, Kana Ono, Jun Sugisaka, Hisashi Shimizu, Hirotaka Ono, Yutaka Domeki, Tomoiki Aiba, Sachiko Kawana, Ryohei Saito, Keisuke Terayama, Yosuke Kawashima, Atsushi Nakamura, Shinsuke Yamanda, Yuichiro Kimura, Yoshihiro Honda
- Abstract
Loading... -
+
P1.16-30 - Impact of Patient TKI Copayments on Insurance Expenditure in Advanced EGFR or ALK Positive Non-Small Cell Lung Cancer (NSCLC)
09:45 - 09:45 | Presenter: Bernardo Haddock Lobo Goulart | Author(s): Shasank Chennupati, Kathryn S Egan, Catherine R Fedorenko, Scott D Ramsey
- Abstract
Loading... -
+
P1.16-31 - Body Mass Index Relating to Patient-Reported Symptoms in First-Line Treatment of Metastatic Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: George R Simon | Author(s): Qiuling Shi, Loretta Ann Williams, Belqis El Ferjani, Meita S Hirschmann, Darcy Ponce, Seyedeh S Dibaj, Sheenu Chandwani, Emily Roarty, Waree Rinsurongkawong, Jeff Lewis, Thomas Burke, Charles S Cleeland, Jack Lee, Jack Roth, Stephen Swisher, John Victor Heymach, Jianjun Zhang
- Abstract
Loading... -
+
P1.16-32 - Empowering Lung Cancer Survivors and Family Members to “Breathe Easier”: Adaptation and Evaluation of a M-Health Intervention
09:45 - 09:45 | Presenter: Otis LeShaun Owens | Author(s): Karen Kane McDonnell, Jenay M Beer, David G. Gallerani
- Abstract
Loading... -
+
P1.16-33 - From a Systematic Review to Real World Evidence: Integrating Gender as a Clinical Risk Factor in NSCLC
09:45 - 09:45 | Presenter: Gwyn Bebb | Author(s): Noor Asaad Alsaadoun, Karen Kopciuk, Desiree Hao, Fu Hao, Anifat A Elegbede, Amanda Jane Williams Gibson, Michelle L Dean, Roxana A Tudor
- Abstract
Loading... -
+
P1.16-34 - Association Between Skin Reactions and Clinical Benefit in Patients Treated with Anti-PD-1 Treatment for Advanced Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Mari Aso | Author(s): Shunichi Sugawara, Yukihiro Toi, Jun Sugisaka, Hirotaka Ono, Tomoiki Aiba, Sachiko Kawana, Ryohei Saito, Kyoji Tsurumi, Kana Ono, Hisashi Shimizu, Yutaka Domeki, Keisuke Terayama, Yosuke Kawashima, Atsushi Nakamura, Shinsuke Yamanda, Yuichiro Kimura, Yoshihiro Honda
- Abstract
Loading... -
+
P1.16-35 - The Prognostic Impact of Sarcopenia on the Clinical Outcome of Thoracic Surgery for Non-Small Cell Lung Cancer in Elderly Patients
09:45 - 09:45 | Presenter: Akihiro Miura | Author(s): Junichi Soh, Shunsaku Miyauchi, Kota Araki, Kentaro Nakata, Kei Namba, Ken Suzawa, Shinji Otani, Hiromasa Yamamoto, Mikio Okazaki, Seiichiro Sugimoto, Masaomi Yamane, Shinichi Toyooka
- Abstract
Loading... -
+
P1.16-36 - Treatment Patterns Among Patients with EGFRm NSCLC Treated in the US Community Oncology Setting
09:45 - 09:45 | Presenter: Melissa Pavilack | Author(s): Eric Nadler, Jamyia Clark, Janet L. Espirito, Ancilla W. Fernandes
- Abstract
Loading... -
+
P1.16-37 - Correlation Between the Actual Measurement Value After Lung Lobectomy and the Predicted Value of Forced Expiratory Volume in 1 Second
09:45 - 09:45 | Presenter: Tatsuya Hayashi | Author(s): Yoshifumi Sano, Hisayuki Shigematsu, Ryujiro Sugimoto, Nobuhiko Sakao, Tomohisa Sakaue
- Abstract
Loading... -
+
P1.16-38 - Racial Disparities in Long-Term Survival After Surgical Resection in the US
09:45 - 09:45 | Presenter: Meghan Taylor | Author(s): Matthew P Smeltzer, Nicholas Faris, Meredith Ray, Carrie Fehnel, Cheryl Houston-Harris, Olawale Akinbobola, Philip Ojeabulu, Ray Osarogiagbon
- Abstract
Loading... -
+
P1.16-39 - Oncology Emergencies in Patients with Lung Cancer: Experience of One Hospital
09:45 - 09:45 | Presenter: Marta Vilaça | Author(s): Élia Cipriano, Alda Tavares, Adriana Soares, Fernanda Estevinho, Carlos Sottomayor
- Abstract
Loading... -
+
P1.16-40 - Real-World Neurocognitive Function in Lung Cancer: Initial Results of the PRO-Long Study
09:45 - 09:45 | Presenter: Lotte Anna Van Der Weijst | Author(s): Veerle Surmont, Wim Schrauwen, Yolande Lievens
- Abstract
Loading... -
+
P1.16-41 - Timing, Sites, and Correlates of Lung Cancer Recurrence: The Missing Pieces in National Datasets
09:45 - 09:45 | Presenter: David E. Gerber | Author(s): Chelsea M Karacz, Jingsheng Yan, Hong Zhu, Alejandra Madrigales
- Abstract
Loading... -
+
P1.16-42 - Real-World Trends in Systemic Anticancer Therapy (SACT) for Squamous Advanced NSCLC (aNSCLC) in the US, 2011–2018
09:45 - 09:45 | Presenter: Vamsidhar Velcheti | Author(s): Sheenu Chandwani, Xin Chen, Bilal Piperdi, Thomas Burke
- Abstract
Loading... -
+
P1.16-43 - Prevalence of Clinical and Sub-Clinical Malnutrition in Advanced Non-Small-Cell Lung Cancer Patients and Association with Outcome
09:45 - 09:45 | Presenter: Sara Pilotto | Author(s): Ilaria Trestini, Isabella Sperduti, Marco Sposito, Dzenete Kadrija, Alessandro Drudi, Daniela Tregnago, Alice Avancini, Vincenzo Pio Di Noia, Anastasios Gkountakos, Ettore D'Argento, Luisa Carbognin, Massimo Lanza, Antonio Santo, Mirko D'Onofrio, Giampaolo Tortora, Emilio Bria, Michele Milella
- Abstract
Loading... -
+
P1.16-44 - Multiple Primary Cancers (MPC) in a Cohort of Lung Cancer (LC) Patients (P): Incidence and Clinical Features
09:45 - 09:45 | Presenter: Carlos Erasun Lecuona | Author(s): Andrea Gonzalez, Anna Esteve, Marta Domenech, Eudald Felip, Marc Cucurull, Laura Angelats, Sofia España, Angelica Ferrando, Andrea Plaja, Lucia Notario, Anna Pous, Teresa Moran, Enric Carcereny
- Abstract
Loading... -
+
P1.16-45 - Changing Attitudes Regarding Lung Cancer: Shame, Embarrassment, and Hope
09:45 - 09:45 | Presenter: Joan H Schiller | Author(s): Holli Kolkey, Meghan Cox, Colin Tucker Smith
- Abstract
Loading... -
+
P1.16-46 - Genetic Testing Patterns, Treatment Characteristics, and Overall Survival in ALK-Positive Metastatic NSCLC Patients Treated with Ceritinib
09:45 - 09:45 | Presenter: Julien Mazieres | Author(s): Myung-Ju Ahn, Christos Chouaid, Anna Kron, Juergen Wolf, Ravi K. Goyal, Keith L Davis, Maurice Perrinjaquet, Timothy Pham, Stefanie Knoll
- Abstract
Loading... -
+
P1.16-47 - Embedding Research (and Evidence) in Cancer Healthcare - EnRICH
09:45 - 09:45 | Presenter: Bea Brown | Author(s): John Simes, Michael Boyer, Phillip Hogg, Anthony Joshua, Jane Young
- Abstract
Loading... -
+
P1.16-48 - Experiences of Pts on 1st Line Care (EP1C): Symptoms and Impacts of EGFR TKI Therapy on Real-World Daily Lives of NSCLC Pts
09:45 - 09:45 | Presenter: Ivy Elkins | Author(s): Rodolfo Bordoni, Rahul Shenolikar, Anna Ryden, Mona Martin, Nicolaas A. Bakker, Helena Chung, Jill Feldman
- Abstract
Loading...
-
+
P1.17 - Treatment of Early Stage/Localized Disease
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Treatment of Early Stage/Localized Disease
-
+
P1.17-01 - Surgical Outcome of Early Stage Lung Cancer Related vs Unrelated to Honeycomb Lesions with Interstitial Pneumonia
09:45 - 09:45 | Presenter: Makoto Fujiwara | Author(s): Yasuhiro Tsutani, Takahiro Mimae, Yoshihiro Miyata, Morihito Okada
- Abstract
Loading... -
+
P1.17-02 - The Investigation of Intraoperative Marking by Transbronchial Low Power Laser Irradiation in Human Lung
09:45 - 09:45 | Presenter: Keishi Ohtani | Author(s): Sachio Maehara, Kentaro Imai, Hideyuki Furumoto, Naohiro Kajiwara, Tatsuo Ohira, Norihiko Ikeda
- Abstract
Loading... -
+
P1.17-03 - Inter-Fraction Variability of 18-FDG PET During Lung SBRT and the Effect of Systemic and Immunotherapy: Results of a Prospective Pilot Study
09:45 - 09:45 | Presenter: Sibo Tian | Author(s): Jeffrey M Switchenko, Ila Sethi, Xiaofeng Yang, Angela J Da Silva, Taofeek Owonikoko, David M Schuster, Walter J Curran, Kristin A Higgins
- Abstract
Loading... -
+
P1.17-04 - Multicenter Observational Study of Node-Negative Non-Small Cell Lung Cancer Patients Who Are Excluded from a Clinical Trial
09:45 - 09:45 | Presenter: Hiroyuki Sakurai | Author(s): Yasushi Goto, Kiyotaka Yoh, Kazuya Takamochi, Takehito Shukuya, Tomoyuki Hishida, Masahiro Tsuboi, Koichi Yoshida, Yasuhisa Ohde, Sakae Okumura, Yasuo Ohashi, Hideo Kunitoh
- Abstract
Loading... -
+
P1.17-05 - What Is the Optimal Number of Examined Lymph Node in Stage IA Non-Small Cell Lung Cancer?
09:45 - 09:45 | Presenter: Yuan Chen | Author(s): Liu Huang, Vanisha Chummun, Wei Zhang, Qian Chu
- Abstract
Loading... -
+
P1.17-06 - Long-Term Oncological Outcome After Thoracoscopic Lobectomy for Non-Small Cell Lung Cancer Patients
09:45 - 09:45 | Presenter: Masayuki Nakao | Author(s): Junji Ichinose, Yosuke Matsuura, Sakae Okumura, Mingyon Mun
- Abstract
Loading... -
+
P1.17-07 - Neoadjuvant Gefitinib in Resectable Early Stage EGFR Mutant Non-Small Cell Lung Cancer (NSCLC): A Window-of-Opportunity Study
09:45 - 09:45 | Presenter: Aaron C Tan | Author(s): Khi Pin Chua, Angela Takano, Jacob Alvarez, Boon Hean Ong, Tina Koh, Zaw Win Aung, Amit Jain, Gillianne Lai, Wan Ling Tan, Mei Kim Ang, Quan Sing Ng, Ravindran Kanesvaran, Tanujaa Rajasekaran, N Gopalakrishna Iyer, Wan Teck Lim, Weiwei Zhai, Chee Keong Toh, Anders Skanderup, Eng Huat Tan, Daniel SW Tan
- Abstract
Loading... -
+
P1.17-08 - mRNA Expression Level of Receptor Tyrosine Kinases and Non-Receptor Tyrosine Kinases as a Recurrence Risk in Resected Adenocarcinoma of the Lung
09:45 - 09:45 | Presenter: Masaoki Ito | Author(s): Mireia Serra, Ramon Rami-Porta, Jose Belda-Sanchis, Imane Chaib, Morihito Okada, Niki Karachaliou, Rafael Rosell
- Abstract
Loading... -
+
P1.17-09 - Surgical Outcomes of Complex Versus Simple Segmentectomy for Stage I Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Yoshinori Handa | Author(s): Yasuhiro Tsutani, Atsushi Kagimoto, Takahiro Mimae, Yoshihiro Miyata, Morihito Okada
- Abstract
Loading... -
+
P1.17-10 - Prediction of Visceral Pleural Invasion in c-N0 Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Satoru Okada | Author(s): Aritoshi Hattori, Takeshi Matsunaga, Kazuya Takamochi, Shiaki Oh, Masayoshi Inoue, Kenji Suzuki
- Abstract
Loading... -
+
P1.17-11 - Nomogram Predicting Overall Survival Benefit of Stereotactic Ablative Radiotherapy for Early Stage Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Corbin D Jacobs | Author(s): Junheng Gao, Xiaofei Wang, Kurren Mehta, Joseph K Salama, Jordan A Torok, Chris R Kelsey
- Abstract
Loading... -
+
P1.17-12 - Osteogenic and Brain Metastases After Resection of NSCLC: Implications for the Use of FDG-PET and Brain MRI in Postoperative Surveillance
09:45 - 09:45 | Presenter: Tetsuya Mizuno | Author(s): Hayato Konno, Hideaki Kojima, Mitsuhiro Isaka, Yasuhisa Ohde
- Abstract
Loading... -
+
P1.17-13 - Next Generation Sequencing of the Circulating Small RNA from Serum Identifies Small RNA-Based Biomarker Panel for Stage I-II Lung Adenocarcinoma
09:45 - 09:45 | Presenter: Daisuke Ueda | Author(s): Yasuhiro Tsutani, Takahiro Mimae, Yoshihiro Miyata, Morihito Okada, Hidetoshi Tahara
- Abstract
Loading... -
+
P1.17-14 - Prognostic Value of Immune Cell Biomarkers in Surgically Resectable Non-Small Cell Lung Cancer: A Meta-Analysis
09:45 - 09:45 | Presenter: Stephanie Tuminello | Author(s): Rajwanth Veluswamy, Wil Lieberman-Cribbin, Sacha Gnjatic, Francesca Petralia, Pei Wang, Raja Flores, Maaike Van Gerwen
- Abstract
Loading... -
+
P1.17-15 - Risk, Pattern and Outcome of Brain Metastases in Completely Resected Stage I (AJCC 8th Edition) Non-Squamous Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Jianjiao Ni | Author(s): tiantian Guo, Yuan Li, Zhengfei Zhu
- Abstract
Loading... -
+
P1.17-16 - Neo-Adjuvant Targeted Therapy in Non-Small Cell Lung Cancer Patients: A 10-Year Experience in a Tertiary Medical Center
09:45 - 09:45 | Presenter: Hsu Ching Huang | Author(s): Chao-Hua Chiu, Chi-Lu Chiang, Yung-Hung Luo, Chun-Ming Tsai, Yuh-Min Chen
- Abstract
Loading... -
+
P1.17-17 - Outcomes Following Stereotactic Body Radiotherapy (SBRT) for Biopsy-Confirmed vs. Radiologically-Diagnosed Primary Lung Cancer
09:45 - 09:45 | Presenter: Tze Lui Koh | Author(s): Wee Ong, Tracy Leong, Carminia Lapuz, Adeline Lim
- Abstract
Loading... -
+
P1.17-18 - Surgery Alone or Plus Adjuvant Radiotherapy for Patients with N0 Non-Small-Cell Lung Cancer >5 cm: A Population-Based Study
09:45 - 09:45 | Presenter: Junmiao Wen | Author(s): Jiayan Chen, Min Fan, Xinyan Xu, Di Liu
- Abstract
Loading... -
+
P1.17-19 - Lobe-Specific Lymph Node Dissection for Clinical Early-Stage (cIA) Peripheral Non-Small Cell Lung Cancer Patients: Feasible and How?
09:45 - 09:45 | Presenter: Han-Yu Deng | Author(s): Qinghua Zhou
- Abstract
Loading... -
+
P1.17-20 - Evaluation of Efficacy and Safety of Uniportal Segmentectomy in the Treatment of Lung Cancer
09:45 - 09:45 | Presenter: Chenlei Zhang | Author(s): Gebang Wang, Zhanwu Yu, Hong-Xu Liu
- Abstract
Loading... -
+
P1.17-21 - Safety and Effectiveness of Stereotactic Ablative Radiotherapy for Ultra-Central Lung Lesions: A Systematic Review
09:45 - 09:45 | Presenter: Hanbo Chen | Author(s): Joanna Laba, Sondos Zayed, Gabe Boldt, David A Palma, Alexander Vincent Louie
- Abstract
Loading... -
+
P1.17-22 - Do Statins Improve Outcomes After Radical Radiotherapy for Lung Cancer? An In-Depth Analysis of Over 1100 Patients
09:45 - 09:45 | Presenter: Fei Sun | Author(s): Louise Murray, John Lilley, Kathryn Elizabeth Banfill, Bob Wheller, Alan McWilliam, Azadeh Abravan, Marcel Van Herk, Corinne Faivre-Finn, Kevin Franks
- Abstract
Loading... -
+
P1.17-23 - Outcome After Surgical Resection for Clinical Stage I Non-Small Cell Lung Cancer Associated with Interstitial Lung Disease
09:45 - 09:45 | Presenter: Takahisa Koizumi | Author(s): Tatsuhiko Hirono, Takehiro Watanabe
- Abstract
Loading... -
+
P1.17-24 - Treatment of Ultracentral Lung Tumors with Hypofractionated Radiation Therapy
09:45 - 09:45 | Presenter: Tamara Nsouli | Author(s): Ryan Alden, William Ennis, Michael Mix, Jeffrey Bogart
- Abstract
Loading... -
+
P1.17-25 - Outcomes of Primary Lung Cancer SBRT in Patients with Compromised Lung Function
09:45 - 09:45 | Presenter: Elaine Kirby | Author(s): Anoop Haridass, Anthony Pope, Marie McKay, Helen Wong
- Abstract
Loading... -
+
P1.17-26 - Delivery of Stereotactic MR-Guided Adaptive Radiation Therapy for Peripheral Lung Tumors
09:45 - 09:45 | Presenter: Tobias Finazzi | Author(s): Miguel Palacios, Cornelis Haasbeek, Marjan Admiraal, Femke Spoelstra, Anna Bruynzeel, Ben Slotman, Frank Lagerwaard, Suresh Senan
- Abstract
Loading... -
+
P1.17-27 - Stereotactic Radiotherapy for Primary Lung Tumors: The Influence of Size
09:45 - 09:45 | Presenter: Isabel Rodrigues | Author(s): Tiago Figueiredo, João Gagean, Carolina Ferreira, André Laranja, Tiago Ramos, Sofia Conde, Diana Moreira, Luisa Carvalho, Joana Cardia
- Abstract
Loading... -
+
P1.17-28 - Refusal of Surgery for Early Stage Lung Cancer: Risk Factors and Survival
09:45 - 09:45 | Presenter: Wil Lieberman-Cribbin | Author(s): Joseph Rapp, Stephanie Tuminello, Raja Flores, Maaike Van Gerwen
- Abstract
Loading... -
+
P1.17-29 - 8-year Experience of Navigational Bronchoscopy for Preoperative Localization of Subcentimeter Lung Nodules in a Small Community Hospital
09:45 - 09:45 | Presenter: Patrick Craft | Author(s): Christian Rodolfo Galvez-Padilla, Kelsey Baran, Shaun Gallagher
- Abstract
Loading... -
+
P1.17-30 - Sex and Age-Associated Survival Following Resected Early Stage Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Amanda Jane Williams Gibson | Author(s): Adrijana D'Silva, Michelle L Dean, Roxana A Tudor, Anifat A Elegbede, Shannon Mary Otsuka, Gwyn Bebb
- Abstract
Loading... -
+
P1.17-31 - VATS Segmentectomies Are at Least as Safe as VATS Lobectomies
09:45 - 09:45 | Presenter: Tomasz Marjanski | Author(s): Robert Dziedzic, Marcin Ostrowski, Peter Kanyion, Aleksandra Mosiewicz, Witold Rzyman
- Abstract
Loading... -
+
P1.17-32 - The 8th Editions of the AJCC Staging System in Terms of Predicting Recurrence and Survival in Resected NSCLC Long-Term Survivors
09:45 - 09:45 | Presenter: Seung Hwan Song | Author(s): Seokkee Lee, Jee Won Suh, Seong Yong Park, Chang Young Lee, Dae Joon Kim, Hyo Chae Paik, Kyung Young Chung, Jin Gu Lee
- Abstract
Loading... -
+
P1.17-34 - Prognostic Significance of Preoperative CT-Determined Sarcopenia and Radiodensity in Resected Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Eun Young Kim | Author(s): Kun Woo Kim, Young Saing Kim, Hee Kyung Ahn, Shin Myung Kang
- Abstract
Loading... -
+
P1.17-35 - Solid Predominant Subtype Is an Independent Risk Factor for Recurrence in Patients with Pathologic Stage I Adenocarcinoma
09:45 - 09:45 | Presenter: Kisung Park
- Abstract
Loading... -
+
P1.17-36 - Analyses of Segmental and Intrapulmonary Lymph Node Metastases of Small-Sized Peripheral Solid Predominant Non-Small Cell Lung Cancer (NSCLC)
09:45 - 09:45 | Presenter: Hayato Konno | Author(s): Mitsuhiro Isaka, Tetsuya Mizuno, Hideaki Kojima, Yasuhisa Ohde
- Abstract
Loading... -
+
P1.17-37 - Minimally Invasive Open Surgery (MIOS) for Clinical Stage I Lung Cancer: Perioperative Outcomes in Recent 5 Years
09:45 - 09:45 | Presenter: Kazuo Nakagawa | Author(s): Masaya Yotsukura, Yukihiro Yoshida, Shun-ichi Watanabe
- Abstract
Loading... -
+
P1.17-38 - Does Use of Epidural Anesthesia Affects Survival of Resectable NSCLC? Analysis from a Japanese Nationwide Database
09:45 - 09:45 | Presenter: Kento James Fukumoto | Author(s): Taisuke Jo, Hideo Yasunaga, Jun Nakajima
- Abstract
Loading... -
+
P1.17-39 - Preoperative Prediction of Incomplete Resection in Non-Small Cell Lung Cancer: An Externally Validated Clinical Nomogram
09:45 - 09:45 | Presenter: Marnix Rasing | Author(s): Max Peters, Amy Moreno, Erik Hofman, Judith Herder, Pim Welvaart, Franz Schramel, Joyce Lodeweges, Steven H Lin, Joost Verhoeff, Peter Van Rossum
- Abstract
Loading... -
+
P1.17-40 - Clinical Implications of Using Circulating Tumor DNA to Assess Minimal Residual Disease (MRD) in Patients with NSCLC After Definitive Treatment
09:45 - 09:45 | Presenter: Nicholas I. Simon | Author(s): Young Kwang Chae, Nisha Anjali Mohindra, Victoria Meucci Villaflor
- Abstract
Loading... -
+
P1.17-41 - Preoperative Prognostic Nutritional Index (PNI) as a Prognostic Factor in Patients with Clinical Stage I Non-Small-Cell Lung Cancer
09:45 - 09:45 | Presenter: Mitsuyoshi Matsumoto | Author(s): Kiyohiko Hagiwara, Hiroyasu Komuro, Yusaku Miyamoto, Hirotaka Yamamoto, Koyo Shirahashi, Kiyoshi Doi, Hisashi Iwata
- Abstract
Loading... -
+
P1.17-42 - The Importance of Lymphatic and Vascular Invasion in Stage 1 Non-Small Cell Lung Cancer and Definition of a Totally Curable Tumors
09:45 - 09:45 | Presenter: Akif Turna | Author(s): Hüseyin Melek, Ismail Sarbay, Hasan Volkan Kara, Cengiz Gebitekin, Kamil Kaynak
- Abstract
Loading... -
+
P1.17-43 - Sublober Resection for Adenocarcinoma in Situ Diagnosed by Intraoperative Frozen Sections
09:45 - 09:45 | Presenter: Toshiyuki Shima
- Abstract
Loading...
-
+
P1.18 - Treatment of Locoregional Disease - NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Treatment of Locoregional Disease - NSCLC
-
+
P1.18-01 - RELAY EU/US Subset: Ramucirumab Plus Erlotinib Improves Progression-Free Survival in First-Line EGFR Mutation-Positive NSCLC
09:45 - 09:45 | Presenter: Santiago Ponce Aix | Author(s): Silvia Novello, Edward Garon, Kazuhiko Nakagawa, Ernest Nadal, Denis Moro-Sibilot, Miriam Alonso Garcia, Elizabeth Fabre, Bente Frimodt-Moller, Annamaria Hayden Zimmermann, Carla M Visseren-Grul, Martin Reck
- Abstract
Loading... -
+
P1.18-02 - The AEGEAN Phase 3 Trial of Neoadjuvant/Adjuvant Durvalumab in Patients with Resectable Stage II/III NSCLC
09:45 - 09:45 | Presenter: John Victor Heymach | Author(s): Janis M Taube, Tetsuya Mitsudomi, David Harpole, Mike Aperghis, Leonardo Trani, Mark Powell, Phillip Dennis, Martin Reck
- Abstract
Loading... -
+
P1.18-03 - How to Predict High Grade Radiation Pneumonitis in Non-Small Cell Lung Cancer Patients Treated with Thoracic Radiotherapy
09:45 - 09:45 | Presenter: Jaume Bordas-Martinez | Author(s): Cristina Martin-Cabeza, Susana Padrones-Sánchez, Ramon Palmero Sánchez, Ernest Nadal, Valentin Navarro-Párez, Jordi Dorca-Sargatal, Arturo Navarro-Martín, Samantha Aso-González
- Abstract
Loading... -
+
P1.18-04 - Neoadjuvant Ceritinib for Locally Advanced Non-Small Cell Lung Cancer with ALK Rearrangement: SAKULA Trial
09:45 - 09:45 | Presenter: Yoshitaka Zenke | Author(s): Kiyotaka Yoh, Jun Sakakibara-Konishi, Haruko Daga, Yukio Hosomi, Naoyuki Nogami, Isamu Okamoto, Shingo Matsumoto, Sakiko Kuroda, Masashi Wakabayashi, Shogo Nomura, Genichiro Ishii, Akihiro Sato, Masahiro Tsuboi, Koichi Goto
- Abstract
Loading... -
+
P1.18-05 - ChemoXRT W/ Consolidation Pembrolizumab in Unresectable Stage III NSCLC: Long-Term Survival Update and Analysis of Post-Progression Therapy
09:45 - 09:45 | Presenter: Greg Durm | Author(s): Sandra Althouse, Ahad Sadiq, Shadia I Jalal, Salma Jabbour, Robin Zon, Goetz H. Kloecker, Michael Williamson, Karen L Reckamp, Ebenezer Kio, Robert Langdon, Bamidele Adesunloye, Ryan D Gentzler, Wael Harb, Radhika Walling, Christina Yeon, Marianna Koczywas, Nasser Hanna
- Abstract
Loading... -
+
P1.18-06 - Efficacy and Safety of Neoadjuvant PD-1 Blockade with Sintilimab in Resectable Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Shuhang Wang | Author(s): Ning Li, Jianming Ying, Xiuli Tao, Fan Zhang, Ziran Zhao, Yun Ling, Yushun Gao, Jun Zhao, Qi Xue, Yousheng Mao, Wendong Lei, Ning Wu, Jianchun Duan, Yibo Gao, Zhijie Wang, Nan Sun, Jie Wang, Shugeng Gao, Jie He, Hui Zhou, Shuyan Wang
- Abstract
Loading... -
+
P1.18-07 - Postoperative Complications and Long-Term Survival Among Octogenarians Treated Surgically for Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Masanori Shimomura | Author(s): Hiroaki Tsunezuka, Satoru Okada, Shunta Ishihara, Narumi Ishikawa, Satoshi Ikebe, Tatsuo Furuya, Kenji Kameyama, Shuichi Kitaoka, Junichi Shimada, Masayoshi Inoue
- Abstract
Loading... -
+
P1.18-08 - Survival Outcomes of Salvage Therapy for Locoregionally Recurrent Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Sara Mieko Moore | Author(s): Bonnie Leung, Jonn Wu, Cheryl Ho
- Abstract
Loading... -
+
P1.18-09 - Trimodal Treatment of Locally Advanced Non-Small Cell Lung Cancer: Model-Based Comparison with Chemoradiation Only
09:45 - 09:45 | Presenter: Malene Strange | Author(s): Ivan Richter Vogelius, Lotte Nygaard, Mette Pøhl, Jesper Ravn, Thomas Vejen Lacoppidan, Rene Horsleben Petersen, Gitte Fredberg Persson
- Abstract
Loading... -
+
P1.18-10 - The Prognostic Impact of the Extent of Nodal Involvement in NSCLC Treated with Radical Chemoradiation
09:45 - 09:45 | Presenter: Connie Yip | Author(s): Sze Huey Tan, Kevin Chua, Tian Rui Siow, Anuradha Thiagarajan, Kam Weng Fong, Swee Peng Yap, Wee Loon Ng, Brendan Seng Hup Chia, Joey Yan Leng Tan
- Abstract
Loading... -
+
P1.18-11 - Dose Dense Paclitaxel and Carboplatin as Neoadjuvant Therapy for Resectable/Borderline Resectable NSCLC - A Phase II Trial
09:45 - 09:45 | Presenter: Abhenil Mittal | Author(s): Prabhat Singh Malik, Sunil Kumar, Deepali Jain, Sushmita Pathy
- Abstract
Loading... -
+
P1.18-12 - PACIFIC-4/RTOG 3515: Phase III Study of Durvalumab Following SBRT for Unresected Stage I/II, Lymph-Node Negative NSCLC
09:45 - 09:45 | Presenter: Chen Hu | Author(s): Clifford Robinson, Mitchell Machtay, Michael Newton, Kevin Wu, Karen Barrett, Phillip Dennis, Jeffrey D Bradley
- Abstract
Loading... -
+
P1.18-13 - Predicting Failure Patterns in Patients with Inoperable Local Advanced Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy
09:45 - 09:45 | Presenter: Xueru Zhu | Author(s): Xiaoyang Li, Xiaolong Fu
- Abstract
Loading... -
+
P1.18-14 - The Prognostic Significance of Significant Weight Loss in Stage III NSCLC Undergoing Definitive CRT After FDG-PET Staging
09:45 - 09:45 | Presenter: Clare Senko | Author(s): Julie Moore, Karen Hay, Zarnie Lwin, Gary Pratt, Kwun M Fong, Brett GM Hughes
- Abstract
Loading... -
+
P1.18-15 - Dosimetric and Toxicity Benefits of Adaptive IMRT in Patients with Stage III Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Yinnan Meng | Author(s): Liqiao Hou, Pinjun Gu, Wei Wang, Yichao Shen, Suna Zhou, Feng-Ming Spring Kong, Haihua Yang
- Abstract
Loading... -
+
P1.18-16 - Is Tumor Shrinking During Chemoradiation for LA-NSCLC a Biomarker for Outcome?
09:45 - 09:45 | Presenter: Sara Ramella | Author(s): Sonia Silipigni, Michele Fiore, Carlo Greco, Edy Ippolito, Paola Zuccoli, Bianca Santo, Rolando Maria D'Angelillo
- Abstract
Loading... -
+
P1.18-17 - Survival After Adjuvant Chemotherapy in Completely Resected N1 Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Emily Wang | Author(s): Étienne Bourdages-Pageau, Hugo Gagnon, Catherine Labbe, Lise Tremblay, Paula Antonia Ugalde
- Abstract
Loading... -
+
P1.18-18 - Feasibility of Hypofractionated Chemoradiation for Patients with Stage III Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Noelle Caroline Van Der Voort Van Zyp | Author(s): Masomah Hashimzadah, Erik Kouwenhoven, Klaar Maas, Wolter Oosterhuis, Iris Walraven, José Belderbos, Mirjam Mast
- Abstract
Loading... -
+
P1.18-19 - Invasive Mediastinal Staging Is Mandatory for Upfront Surgery for N2 Disease
09:45 - 09:45 | Presenter: Andrew Selvaraj | Author(s): Kelvin Lau, Georgios Sotiropoulos, Al-Rehan Dhanji, David Waller
- Abstract
Loading... -
+
P1.18-20 - The Relationship Between the Recurrence Timing and Inflammation-Based Prognostic Scores in Resected Non-Small-Cell Lung Cancer
09:45 - 09:45 | Presenter: Daisuke Noma | Author(s): Katsuya Watanabe, Munetaka Masuda
- Abstract
Loading... -
+
P1.18-21 - Short and Mid-Term Outcomes of Multimodal Treatment for Locally-Advanced Non Small Cell Lung Cancer in Elderly Patients
09:45 - 09:45 | Presenter: Francesca Mazzoni | Author(s): stefano Bongiolatti, sara Borgianni, alessandro Gonfiotti, alberto Salvicchi, lorenzo Antonuzzo, luca Voltolini
- Abstract
Loading... -
+
P1.18-22 - Impact of Using Volumetric Modulated Arc Therapy on Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Nobuki Imano | Author(s): Tomoki Kimura, Tsubasa Kameoka, Masanori Ochi, Yuki Takeuchi, Ippei Takahashi, Ikuno Nishibuchi, Yuji Murakami, Daisuke Kawahara, Kentaro Miki, Akito Saito, Nagata Yasushi
- Abstract
Loading... -
+
P1.18-23 - Use of Perfusion SPECT to Preserve Functional Lung in Radiotherapy for Non-Small-Cell Lung Cancer (NSCLC) Patients
09:45 - 09:45 | Presenter: Sara Ramella | Author(s): Carlo Greco, Edy Ippolito, Michele Fiore, Silvia Gentile, Marianna Miele, Rolando Maria D'Angelillo
- Abstract
Loading... -
+
P1.18-24 - Neoadjuvant Therapy versus Upfront Surgery for NSCLC Patients with Clinically Suspected Subaortic or Paraaortic Lymph Nodes
09:45 - 09:45 | Presenter: Junghee Lee | Author(s): Sumin Shin, Jong Ho Cho, Hong Kwan Kim, Yong Soo Choi, Jae Ill Zo, Young Mog Shim, Jhingook Kim
- Abstract
Loading... -
+
P1.18-25 - The Impact of Radiation Pneumonitis on Prognosis of Patients with Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy
09:45 - 09:45 | Presenter: Takahiro Akita | Author(s): Keisuke Baba, Hisashi Tanaka, Ichitaro Fujioka, Sachio Suzuki, Chiori Tabe, Toshihiro Shiratori, Yoshiko Ishioka, Μasamichi Itoga, Kageaki Taima, Junichi Yokouchi, Yukihiro Hasegawa, Shingo Takanashi, Sadatomo Tasaka
- Abstract
Loading... -
+
P1.18-26 - Pretreatment Risk Factors for Postoperative Pulmonary Complication After Neoadjuvant Concurrent Chemoradiotherapy for NSCLC
09:45 - 09:45 | Presenter: Woo Sik Yu | Author(s): Jee Won Suh, Chang Young Lee, Jin Gu Lee, Dae Joon Kim, Hyo Chae Paik, Kyung Young Chung, Seong Yong Park
- Abstract
Loading... -
+
P1.18-27 - Chemoradiotherapy of Inoperable Non-Small Cell Lung Cancer (NSCLC) with IGRT Technique Using TomoTherapy HD
09:45 - 09:45 | Presenter: Milada Zemanova | Author(s): Stanislav Hloušek, Renata Jirásková, Petra Zemanová, Jitka Končeková, Barbora Pejchalová, Tereza Kohlová, Luboš Petruželka
- Abstract
Loading... -
+
P1.18-28 - Salvage Surgery for Residual Lesion/Local Reprogression After Initial Medical Treatment in Advanced Non-Small Cell Lung Cancer
09:45 - 09:45 | Presenter: Keita Nakanishi | Author(s): Hiroaki Kuroda, Takuya Matsui, Suguru Shirai, Harushi Ueno, Noriaki Sakakura
- Abstract
Loading...
-
+
IBS11 - Electronic Cigarettes and Heat-Not-Burn Tobacco Products - How Are They Different (Ticketed Session)
- 07:00 - 08:00
- 9/09/2019
- Location: Amsterdam (2011)
- IASLC CME Accredited
- Type: Interactive Breakfast Session
- Track: Prevention and Tobacco Control
-
+
IBS11.01 - Electronic Cigarettes and Heat-Not-Burn Tobacco Products - How Are They Different
07:00 - 07:10 | Presenter: Maciej L. Goniewicz
- Abstract
Loading... -
+
IBS11.02 - E Cigarettes/ Electronic Nicotine Delivery Systems: A Word of Caution on Health
07:10 - 07:20 | Presenter: Michael Unger
- Abstract
Loading... -
+
IBS11.03 - Cannabis and Lung Cancer
07:20 - 07:30 | Presenter: James Jett
- Abstract
Loading... -
+
IBS11.04 - Q&A
07:30 - 08:00
- Abstract
No abstract available for this presentation
-
+
IBS12 - Case-Based Management of Brain Metastasis (Bm) in Advanced Lung Cancer Patients: Changing the Standards (Ticketed Session)
- 07:00 - 08:00
- 9/09/2019
- Location: Toronto (1985)
- IASLC CME Accredited
- Type: Interactive Breakfast Session
- Track: Advanced NSCLC
-
+
IBS12.01 - Questions to Be Addressed
07:00 - 07:20 | Presenter: Matthias Guckenberger
- Abstract
Loading... -
+
IBS12.02 - Questions to Be Addressed
07:20 - 07:40 | Presenter: Egbert F Smit
- Abstract
Loading... -
+
IBS12.03 - Q&A
07:40 - 08:00
- Abstract
No abstract available for this presentation
-
+
IBS13 - How to Identify and Manage Toxicity in Stage III (Ticketed Session)
- 07:00 - 08:00
- 9/09/2019
- Location: Interlaken (1988)
- IASLC CME Accredited
- Type: Interactive Breakfast Session
- Track: Treatment of Locoregional Disease - NSCLC
-
+
IBS13.01 - Radiation Related Toxicities in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)
07:00 - 07:20 | Presenter: Alexander Sun
- Abstract
Loading... -
+
IBS13.02 - Surgical Management for Perioperative Complications in Advanced Lung Cancer After Chemoradiotherapy
07:20 - 07:40 | Presenter: Hiroshi Date
- Abstract
Loading... -
+
IBS13.03 - Q&A
07:40 - 08:00
- Abstract
No abstract available for this presentation